0001192482-12-000066.txt : 20120309
0001192482-12-000066.hdr.sgml : 20120309
20120309143939
ACCESSION NUMBER: 0001192482-12-000066
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120228
FILED AS OF DATE: 20120309
DATE AS OF CHANGE: 20120309
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HORIZON PHARMA, INC.
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272179987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1033 SKOKIE BLVD
STREET 2: SUITE 355
CITY: NORTHBROOK
STATE: IL
ZIP: 60062
BUSINESS PHONE: 224-383-3000
MAIL ADDRESS:
STREET 1: 1033 SKOKIE BLVD
STREET 2: SUITE 355
CITY: NORTHBROOK
STATE: IL
ZIP: 60062
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Quaker BioVentures II LP
CENTRAL INDEX KEY: 0001497725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 12680208
BUSINESS ADDRESS:
STREET 1: QUAKER BIOVENTURES
STREET 2: 2929 ARCH STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: (215) 988-6800
MAIL ADDRESS:
STREET 1: QUAKER BIOVENTURES
STREET 2: 2929 ARCH STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
3
1
edgar.xml
PRIMARY DOCUMENT
X0204
3
2012-02-28
0
0001492426
HORIZON PHARMA, INC.
HZNP
0001497725
Quaker BioVentures II LP
2929 ARCH STREET
PHILADELPHIA
PA
19104
0
0
1
0
Common Stock
2761477
D
Warrants to Purchase Common Stock
.01
2012-08-22
2017-01-22
Common Stock
546198
D
Warrants to Purchase Common Stock
4.308
2012-02-28
2017-03-02
Common Stock
690369
D
The securities are deemed to be beneficially owned by Quaker BioVentures II, L.P., Quaker BioVentures Capital II, L.P. and Quaker BioVentures Capital II, LLC. Quaker BioVentures Capital II, L.P. is the general partner of Quaker BioVentures II, L.P. Quaker BioVentures Capital II, LLC is the general partner of Quaker BioVentures Capital II, L.P.
Quaker BioVentures II, L.P., By: Quaker BioVentures Capital II, L.P., its general partner, By: Quaker BioVentures Capital II, LLC, its general partner, By: /s/ Richard S. Kollender, Vice President
2012-03-09